Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
Dermata Therapeutics announced the commercial launch of its first direct-to-consumer skincare product, Tome Foundational Treatment, scheduled for August 25, 2026. The product utilizes the company's proprietary Bioneedle technology and will be sold exclusively online as a set of four weekly treatments for $178.
Key figures
- Launch date
- August 25, 2026
- Product price
- $178
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.